Michael A. Schwarzschild

24.6k total citations · 2 hit papers
235 papers, 17.3k citations indexed

About

Michael A. Schwarzschild is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Michael A. Schwarzschild has authored 235 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Neurology, 66 papers in Physiology and 62 papers in Molecular Biology. Recurrent topics in Michael A. Schwarzschild's work include Parkinson's Disease Mechanisms and Treatments (121 papers), Adenosine and Purinergic Signaling (66 papers) and Neurological disorders and treatments (24 papers). Michael A. Schwarzschild is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (121 papers), Adenosine and Purinergic Signaling (66 papers) and Neurological disorders and treatments (24 papers). Michael A. Schwarzschild collaborates with scholars based in United States, China and Italy. Michael A. Schwarzschild's co-authors include Alberto Ascherio, Jiang‐Fan Chen, Alberto Ascherio, Honglei Chen, Xiang Gao, Kui Xu, J. Stephen Fink, Yuehang Xu, Marc G. Weisskopf and David G. Standaert and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michael A. Schwarzschild

225 papers receiving 17.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The epidemiology of Parkinson's disease: risk factors and prevention

2016 1.3k citations Alberto Ascherio, Michael A. Schwarzschild profile →
Incidence of Parkinson disease in North America

2022 164 citations Michael A. Schwarzschild et al. npj Parkinson s Disease profile →

Peers

Michael A. Schwarzschild

NEURO

CMN

PHYSI

NEURO

Robert A. Hauser United States

Diogo O. Souza Brazil

Weidong Le China

Catarina R. Oliveira Portugal

Diego Centonze Italy

Étienne C. Hirsch France

M. Maral Mouradian United States

Kazuhide Inoue Japan

Yoshikuni Mizuno Japan

Stephen D. Skaper Italy

Robert A. Hauser United States

Michael A. Schwarzschild

13.7k ×1.8

NEURO

6.8k ×1.3

CMN

3.0k ×0.7

832 ×0.2

PHYSI

1.4k ×0.5

NEURO

Citations per year, relative to Michael A. Schwarzschild Michael A. Schwarzschild (= 1×) peers Robert A. Hauser

Countries citing papers authored by Michael A. Schwarzschild

Since Specialization

Citations

This map shows the geographic impact of Michael A. Schwarzschild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Schwarzschild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Schwarzschild more than expected).

Fields of papers citing papers by Michael A. Schwarzschild

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Schwarzschild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Schwarzschild. The network helps show where Michael A. Schwarzschild may publish in the future.

Co-authorship network of co-authors of Michael A. Schwarzschild

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Schwarzschild. A scholar is included among the top collaborators of Michael A. Schwarzschild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Schwarzschild. Michael A. Schwarzschild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Xiaohong, et al.. (2025). Prodromal Parkinson’s disease and subsequent risk of Parkinson’s disease and mortality. npj Parkinson s Disease. 11(1). 14–14. 2 indexed citations

Zhang, Xinyuan, Eric A. Macklin, Jian Wang, et al.. (2025). Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohort. EBioMedicine. 119. 105866–105866.

Schootemeijer, Sabine, Nienke M. de Vries, Sirwan K.L. Darweesh, et al.. (2025). Promoting Physical Activity in People With Parkinson’s Disease Through a Smartphone App: A Pilot Study. Journal of Neurologic Physical Therapy. 49(2). 74–81. 5 indexed citations

Mathur, Soania, et al.. (2024). Perspectives of People At-Risk on Parkinson’s Prevention Research. Journal of Parkinson s Disease. 14(3). 399–414. 2 indexed citations

Schwarzschild, Michael A., et al.. (2024). Clearing the Smoke: What Protects Smokers from Parkinson's Disease?. Movement Disorders. 39(2). 267–272. 16 indexed citations

Christine, Chadwick W., Kjetil Bjørnevik, Samantha Molsberry, et al.. (2023). Long‐Term Intake of Folate, Vitamin B6, and Vitamin B12 and the Incidence of Parkinson's Disease in a Sample of U.S. Women and Men. Movement Disorders. 38(5). 866–879. 12 indexed citations

Palacios, Natalia, Jeremy E. Wilkinson, Kjetil Bjørnevik, et al.. (2023). Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes. Annals of Neurology. 94(3). 486–501. 30 indexed citations

Srivastava, Pranay, Shuhei Nishiyama, Fang Zhou, et al.. (2023). Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease. Journal of Neuroimmune Pharmacology. 18(4). 704–717. 4 indexed citations

Luca, Daniel G. Di, Eric A. Macklin, Lindsay Pothier, et al.. (2023). Enrollment of Participants From Marginalized Racial and Ethnic Groups. Neurology Clinical Practice. 13(1). e200113–e200113. 7 indexed citations

10.

Bjørnevik, Kjetil, Albert Y. Hung, Brian C. Healy, et al.. (2023). Subjective Cognitive Decline in Women with Features Suggestive of Prodromal Parkinson's Disease. Movement Disorders. 38(8). 1473–1482. 5 indexed citations

11.

Hung, Albert Y. & Michael A. Schwarzschild. (2020). Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned. Neurotherapeutics. 17(4). 1393–1405. 23 indexed citations

12.

Schwarzschild, Michael A., Eric A. Macklin, Rachit Bakshi, et al.. (2019). Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial. Neurology. 93(14). e1328–e1338. 34 indexed citations

13.

Bhattacharyya, Shamik, Rachit Bakshi, Robert Logan, et al.. (2014). Oral Inosine Persistently Elevates Plasma Antioxidant Capacity in Early Parkinson’s Disease (S37.009). Neurology. 82(10_supplement). 1 indexed citations

14.

Palacios, Natalia, Kathryn C. Fitzgerald, Andrea L. Roberts, et al.. (2014). A Prospective Analysis of Airborne Metal Exposures and Risk of Parkinson Disease in the Nurses’ Health Study Cohort. Environmental Health Perspectives. 122(9). 933–938. 59 indexed citations

15.

Morelli, Micaela, et al.. (2011). The Putative Neuroprotective Effects of Caffeine. 1(2). 91–96.

16.

Leibovich, S. Joseph, Jiang‐Fan Chen, Grace Pinhal‐Enfield, et al.. (2002). Synergistic Up-Regulation of Vascular Endothelial Growth Factor Expression in Murine Macrophages by Adenosine A2A Receptor Agonists and Endotoxin. American Journal Of Pathology. 160(6). 2231–2244. 156 indexed citations

17.

Montesinos, M. Carmen, Avani Desai, Jiang‐Fan Chen, et al.. (2002). Adenosine Promotes Wound Healing and Mediates Angiogenesis in Response to Tissue Injury Via Occupancy of A2A Receptors. American Journal Of Pathology. 160(6). 2009–2018. 194 indexed citations

18.

Schwarzschild, Michael A.. (2002). Translating Adenosine A24 Receptor Biology into Novel Therapies for Parkinson's Disease. Defense Technical Information Center (DTIC). 83(13). 492–3. 2 indexed citations

19.

Schwarzschild, Michael A., Rebecca L. Cole, Melissa A. Meyer, & Steven E. Hyman. (1999). Contrasting Calcium Dependencies of SAPK and ERK Activations by Glutamate in Cultured Striatal Neurons. Journal of Neurochemistry. 72(6). 2248–2255. 43 indexed citations

20.

Schwarzschild, Michael A., Rebecca L. Cole, & Steven E. Hyman. (1997). Glutamate, But Not Dopamine, Stimulates Stress-Activated Protein Kinase and AP-1-Mediated Transcription in Striatal Neurons. Journal of Neuroscience. 17(10). 3455–3466. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact